Clinical trials

New York Valves 2026: Advancing the Future of Structural Heart Disease Treatment The landscape of cardiovascular medicine is set to evolve as the medical community prepares for New York Valves …

Revolution Medicines’ Experimental Cancer Drug Shows Significant Survival Benefit in Pancreatic Cancer Trial On April 13, 2026, Revolution Medicines announced positive results from a Phase III clinical trial of its …

Adenoid Cystic Carcinoma: A Rare Cancer with Complexities Adenoid cystic carcinoma (ACC) is a rare and often challenging cancer that typically develops in the secretory glands, most commonly found in …

Rezatapopt Shows Promise in Restoring Function to Mutant p53 in Early Clinical Trials A fresh study published in Nature Medicine demonstrates that the small molecule rezatapopt can bind to and …

Hope for Advanced Breast Cancer: New Combination Therapy Shows Promise Against Leptomeningeal Metastasis For women with HER2-positive breast cancer that has spread to the brain, a new combination therapy is …

Swedish Biotech Atrogi Doses First Subjects in ATR-258 Trial, Focusing on Muscle Preservation in Obesity Treatment Stockholm-based clinical-stage biotechnology company Atrogi AB has begun dosing participants in a new human …

WHO Task Force Aims to Include Pregnant and Breastfeeding Women in Clinical Trials by 2030 Pregnant and breastfeeding women have historically been underrepresented in medical research, leading to significant gaps …

GLP-1 Receptor Agonists and Cancer Risk: A Comprehensive Update Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes management, have gained significant attention for their role in weight …

China’s Wangli Technology Secures Funding for AI-Powered Digital Mental Health Platform Wangli Technology, a Chinese digital mental health diagnosis and therapy platform, has completed a Series B+ funding round, raising …